FemiCore Ingredient Reference: Nine Components, the Research Behind Each, and the Missing Doses

This page is a lookup sheet for what goes into a FemiCore capsule. Start with the reference table, then jump to any single ingredient for its claimed role, the state of the research and the caution attached to it. For a slower walk through the same nine names, see our long read on the FemiCore ingredients list.

Reference table: all nine ingredients

Every row shows the same thing in the dose column, because the formula is sold as a proprietary blend.

Ingredient	Type	Studied for	Dose on label
Mimosa pudica	Botanical	Lab and animal work only	Not disclosed
Bearberry (uva ursi)	Botanical	Mild lower urinary complaints	Not disclosed
Cranberry extract	Botanical	Repeat UTIs in women	Not disclosed
Granular berberine	Botanical compound	Blood sugar, cholesterol	Not disclosed
L. crispatus	Probiotic	Repeat UTIs (vaginal use)	Not disclosed
L. acidophilus	Probiotic	No bladder data in our research	Not disclosed
L. plantarum	Probiotic	No bladder data in our research	Not disclosed
L. gasseri	Probiotic	No bladder data in our research	Not disclosed
L. casei	Probiotic	No bladder data in our research	Not disclosed

Quick read of the table: one ingredient (cranberry) has a solid human review behind it for urinary infections. One (berberine) has good human data, but for metabolic markers rather than the bladder. The rest range from limited to nothing bladder specific.

The four botanicals

Mimosa pudica

• Role in the formula: presented as a traditional astringent herb for the bladder.
• What research says: reports of anti-inflammatory, antimicrobial and antispasmodic activity come from lab and animal studies. There are no human trials for bladder symptoms. Of all nine, this is the ingredient with the least evidence.
• Caution: no specific warning turned up in our research, but with no human bladder trials there is very little data to judge it either way.

Bearberry (uva ursi)

• Role in the formula: included for its arbutin, linked to urinary cleansing.
• What research says: arbutin is converted to hydroquinone, which shows antibacterial action in the lab when it reaches the urine. Human evidence is limited and mixed. One trial (ATAFUTI) tested uva-ursi extract in women with uncomplicated urinary infections. European herbal regulators recognise traditional use for mild lower urinary complaints and limit it to brief courses, roughly seven days.
• Caution: nausea is possible, and urine may turn green-brown (harmless). It is meant for short-term use, so taking it every day for months sits outside that guidance. Avoid it in pregnancy, while breastfeeding, with kidney disease and in children. It has a known interaction with lithium. The arbutin content is not stated.

Cranberry extract

• Role in the formula: supplies A-type proanthocyanidins (PACs), which reduce how well E. coli bacteria stick to the urinary tract wall.
• What research says: a 2023 Cochrane review concluded that cranberry products can reduce repeat UTIs in women who are prone to them. Earlier reviews were mixed, and the benefit depends on how much PAC is delivered. All of that research is about infections, not leaks or a sudden urge to go.
• Caution: there are case reports of interaction with warfarin, so anyone on it needs their INR watched. Cranberry contains oxalate, a concern for people who form kidney stones. The PAC content of FemiCore is not given.

Granular berberine

• Role in the formula: described as support for the gut environment.
• What research says: berberine has good human data for blood sugar and cholesterol, from studies giving people between 1,000 and 1,500 mg per day. There is no real evidence for the bladder. FemiCore does not say how much berberine one capsule holds.
• Caution: this is the ingredient behind most of the formula’s drug interactions. It can cause stomach and bowel effects, can lower blood sugar (relevant with diabetes medicines), may lower blood pressure, and slows the liver enzymes CYP3A4 and CYP2D6, which can push up levels of drugs such as cyclosporine. It is considered unsafe in pregnancy and breastfeeding. Our FemiCore safety sheet lays out the interactions in table form.

The five probiotic species

The seller lists Lactobacillus species, not strains. That distinction matters, because research results in probiotics apply to a specific strain, identified by a code after the species name, and FemiCore gives no codes.

L. crispatus

• Role in the formula: the lead urogenital species.
• What research says: when researchers gave an L. crispatus product vaginally in a small study against placebo, repeat UTIs went down. FemiCore is swallowed, not used vaginally, and its strain is unknown, so that result does not carry over directly.
• Caution: gas or bloating can show up in the first one to two weeks of any probiotic.

The other four species

Species	Role given by the seller	Bladder evidence found
L. acidophilus	Lactic acid production	None specific
L. plantarum	Gut barrier support	None specific
L. gasseri	Urogenital flora	None specific
L. casei	Digestion support	None specific

These four are common probiotic species. Our research turned up no bladder-specific trials for them, and without strain codes or a CFU count there is nothing to match against other studies. The safety note is the same for all five: gas or bloating early on, and a rare risk of infection in people whose immune system is severely weakened.

Why probiotics are in a bladder formula at all

The idea rests on the urinary microbiome. From about 2012, sequencing studies, some of them run at Loyola University Chicago, detected bacteria living in the female bladder, so it is not a sterile organ. A few of those studies reported lower Lactobacillus levels in women with urgency incontinence. That is a plausible starting point, but it is early science. It does not show that swallowing probiotics changes bladder symptoms. The benefits map scores each label claim against this kind of evidence.

What the label leaves out

Use this as a checklist when reading the label. Every box below stays unticked for FemiCore:

• Amount of each of the nine ingredients
• CFU count for the probiotic part
• Strain codes for the five Lactobacillus species
• PAC content of the cranberry extract
• Arbutin content of the bearberry
• Berberine dose per capsule
• A published certificate of analysis

What the label does state: all nine names, one capsule per serving, 30 capsules per bottle. Two further descriptions come from the seller: no stimulants, and non-GMO.

Reading a proprietary blend: three practical points

1. Order is not proof of amount. Without numbers, an ingredient listed first could still be present in a small quantity.
2. Berberine is the dose that matters most for safety. Its interactions apply whatever the amount, so assume they are relevant.
3. Bearberry is the dose that matters most for duration. Short-course guidance clashes with a product meant to be taken daily for at least 3 months, as the vendor suggests.

For how these gaps feed into our overall judgement, see the FemiCore review page and our methodology.